Dr Natasha Martin
DPhil (Oxon)
Current positions
Visiting Professor
Epidemiology and Health Data Science
Contact
Press and media
Many of our academics speak to the media as experts in their field of research. If you are a journalist, please contact the University’s Media and PR Team:
Research interests
I am an infectious disease modeller based in the Department of Social and Community Medicine, University of Bristol and the Social and Mathematical Epidemiology Group, Department of Global Health and Development, LSHTM. I am currently working with Professor Matthew Hickman and Dr. Peter Vickerman on mathematical models of hepatitis C and HIV prevention among people who inject drugs. Specifically, the majority of my work centres on modeling the impact, cost-effectiveness, and optimal program delivery of HCV treatment as prevention. Additionally, I have worked on economic evaluations and modelling analyses for the National Institute for Clinical Excellence (NICE) and the World Health Organization.
I completed my DPhil in 2009 at the Centre for Mathematical Biology at Oxford University under the supervision of Professor Philip Maini and Dr. Eamonn Gaffney. My thesis focused on mathematical models of tumour acidity and invasion.
Previously, during my undergraduate at Stanford University, I researched phenotypic plasticity of barnacle leg lengths with Professor Mark Denny and mathematical models of chronic myelogenous leukemia with Dr. Helen Moore.
Publications
Recent publications
18/02/2026Assessing the sensitivity and predictive value of wastewater in detection of Hepatitis A cases in San Diego County
PLOS ONE
Optimizing HCV Screening to Maximize Health Benefit Among Men Who Have Sex with Men in the United States: A Cost-Effectiveness Analysis
Clinical Infectious Diseases
Modeling the impact of changing drug markets and structural determinants on HCV and/or HIV transmission among people who inject drugs in the United States: A rural and urban comparison
International Journal of Drug Policy
Quantifying the impact of a large‐scale opioid agonist treatment program on suicide prevention in New South Wales, Australia: A data‐modeling study
Addiction
Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a consortium of prospective cohort studies
The Lancet HIV



